Vera Therapeutics, Inc. (VERA)
53.91
+0.13
(+0.24%)
USD |
NASDAQ |
Dec 23, 16:00
53.70
-0.21
(-0.39%)
Pre-Market: 08:47
Vera Therapeutics SG&A Expense (TTM): 80.89M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.181B |
| Insmed, Inc. | 631.20M |
| MannKind Corp. | 195.42M |
| Madrigal Pharmaceuticals, Inc. | 715.08M |
| Krystal Biotech, Inc. | 136.75M |